CDN1163   Click here for help

GtoPdb Ligand ID: 12968

Compound class: Synthetic organic
Comment: CDN1163 is an allosteric activator of the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) [1]. It blocks endoplasmic reticulum stress caused by dysregulated SERCA function. CDN1163 has been used to study the role of SERCA2 in intracellular Ca2+ homeostasis and endoplasmic reticulum stress, mitochondrial homeostasis and cell viability [2-4,6].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 50.69
Molecular weight 320.39
XLogP 1.98
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)OC1=CC=C(C=C1)C(=O)NC2=C3C(=CC=C2)C=CC(=N3)C
Isomeric SMILES CC(C)OC1=CC=C(C=C1)C(=O)NC2=C3N=C(C)C=CC3=CC=C2
InChI InChI=1S/C20H20N2O2/c1-13(2)24-17-11-9-16(10-12-17)20(23)22-18-6-4-5-15-8-7-14(3)21-19(15)18/h4-13H,1-3H3,(H,22,23)
InChI Key GVGVYDCVFBGALZ-UHFFFAOYSA-N
References
1. Kang S, Dahl R, Hsieh W, Shin A, Zsebo KM, Buettner C, Hajjar RJ, Lebeche D. (2016)
Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders.
J Biol Chem, 291 (10): 5185-98. [PMID:26702054]
2. Kimura T, Kagami K, Sato A, Osaki A, Ito K, Horii S, Toya T, Masaki N, Yasuda R, Nagatomo Y et al.. (2022)
Sarco/Endoplasmic Reticulum Ca2+ ATPase 2 Activator Ameliorates Endothelial Dysfunction; Insulin Resistance in Diabetic Mice.
Cells, 11 (9). [PMID:35563793]
3. Li K, Guo C, Ruan J, Ning B, Wong CK, Shi H, Gu J. (2023)
Cadmium Disrupted ER Ca2+ Homeostasis by Inhibiting SERCA2 Expression and Activity to Induce Apoptosis in Renal Proximal Tubular Cells.
Int J Mol Sci, 24 (6). [PMID:36983052]
4. Nguyen HT, Noriega Polo C, Wiederkehr A, Wollheim CB, Park KS. (2023)
CDN1163, an activator of sarco/endoplasmic reticulum Ca2+ ATPase, up-regulates mitochondrial functions and protects against lipotoxicity in pancreatic β-cells.
Br J Pharmacol, 180 (21): 2762-2776. [PMID:37277321]
5. Sordi G, Goti A, Young HS, Palchetti I, Tadini-Buoninsegni F. (2021)
Stimulation of Ca2+ -ATPase Transport Activity by a Small-Molecule Drug.
ChemMedChem, 16 (21): 3293-3299. [PMID:34297466]
6. Zhang W, Ye F, Pang N, Kessi M, Xiong J, Chen S, Peng J, Yang L, Yin F. (2022)
Restoration of Sarco/Endoplasmic Reticulum Ca2+-ATPase Activity Functions as a Pivotal Therapeutic Target of Anti-Glutamate-Induced Excitotoxicity to Attenuate Endoplasmic Reticulum Ca2+ Depletion.
Front Pharmacol, 13: 877175. [PMID:35517826]